Kodchanut Litleaungdej Md

Nueva
12 años de experiencia
Ubicación: Tailandia, Bangkok
Clínica:
4.8
Intrarat Hospital
El Dr. Kodchanut Litleaungdej es un hematólogo con formación especializada en la atención del linfoma, que aporta experiencia tanto clínica como académica a su práctica en el Hospital Intrarat.
- Graduarse con honores en Medicina por la Universidad de Naresuan
- Completar la especialización en hematología en el Hospital Universitario de Thammasat
- Ser coautor de investigaciones sobre tromboembolismo venoso asociado al cáncer
- Ejercer como hematólogo pionero en el Hospital Huahin con experiencia práctica
- Ser miembro del Comité de Farmacia y Terapéutica, garantizando planes de tratamiento óptimos
Mostrar más

Nueva

Cita con el médico

Precio a consultar

Bookimed Insights: Principales especialistas en Linfoma en Tailandia (2026)

Bookimed ha coordinado 2 solicitudes para el tratamiento de Linfoma en Tailandia, colaborando con 1 especialistas de primer nivel. Los médicos en esta tabla se seleccionan por sus credenciales internacionales, experiencia clínica y resultados de pacientes. La clasificación de 2026 se elabora con datos verificados de casos reales y programas actuales de nuestras clínicas asociadas.

Clasificación	Médico	experiencia	Buena opción para	Qué los distingue	Ubicación de la clínica	Consulta
#1	Kodchanut Litleaungdej Md	12 años de experiencia	Diagnóstico y tratamiento del linfoma	Hematólogo especializado con formación avanzada en la Universidad de Thammasat. Contribuye a la investigación de afecciones relacionadas con el cáncer, mejorando los enfoques de atención personalizada para el paciente.	Intrarat Hospital Tailandia	Precio a consultar

FAQ

Estas preguntas frecuentes provienen de pacientes reales que buscan atención médica a través de Bookimed. Las respuestas son proporcionadas por coordinadores médicos experimentados y representantes autorizados de las clínicas.

What types of lymphoma treatment are available in Thailand?

Thailand offers advanced lymphoma treatments including chemotherapy, immunotherapy, and bone marrow transplantation. JCI-accredited facilities in Bangkok provide CAR T-cell therapy and targeted biological treatments. Academic and private hospitals utilize PET/CT imaging and sentinel lymph node biopsies for precise cancer staging and monitoring.

Systemic therapy: Standard chemotherapy regimens and monoclonal antibodies like Rituximab are available.
Cellular therapy: Leading centers perform autologous and allogeneic bone marrow transplants for relapsed cases.
Advanced diagnostics: Bone marrow biopsy and cytogenetic analysis ensure accurate subtyping of lymphoma.
International standards: Facilities like Bumrungrad International Hospital maintain GHA and ISO quality certifications.

Bookimed Expert Insight: While many choose Bangkok for its 140+ medical centers, the high volume of international patients creates a competitive environment for specialized care. For example, Bumrungrad International Hospital serves over 1 million patients annually with a staff of 1,300 doctors. This scale allows private hospitals to maintain diagnostic equipment that rivals top Western academic institutions.

Patient Consensus: Patients emphasize the necessity of verifying English proficiency and JCI credentials when selecting an oncology department. It is helpful to get detailed quotes upfront to understand exactly what the chemotherapy or immunotherapy bundles include.

Is the quality of lymphoma care in Thailand comparable to major Western centers?

Thai lymphoma care meets Western standards through high-tech diagnostics and expert specialists. Leading Bangkok centers hold JCI and GHA accreditations. They utilize PET-CT scans and advanced bone marrow transplants. Most oncologists possess Western clinical training. Global rankings place major Thai hospitals among the most technologically advanced.

Specialist training: Doctors often hold Thai Board of Hematology and Western fellowships.
Diagnostic tools: Facilities use PET-CT, cytogenetic analysis, and sentinel lymph node biopsy.
Advanced therapies: Centers provide CAR T-cell therapy and allogenic bone marrow transplants.
Global recognition: Bumrungrad International Hospital is a Newsweek-ranked world best hospital.

Bookimed Expert Insight: While many patients focus on Western brands, Thailand’s unique strength is incredible scale. Bumrungrad International Hospital alone handles 1 million patients annually with 1,300 doctors. This high volume across 70 departments means specialists like Dr. Kodchanut Litleaungdej see rare lymphoma subtypes more frequently than typical Western regional centers. This creates a deep practical expertise that clinical textbooks cannot replicate.

What is the usual goal of lymphoma treatment, and how is success measured?

The primary goal of lymphoma treatment is achieving a permanent cure or long-term remission. Success is measured by tracking tumor shrinkage through PET/CT scans and analyzing blood markers. Physicians aim to eradicate all detectable cancer cells while maintaining the patient's long-term quality of life.

Complete response: All physical signs and imaging evidence of lymphoma have fully disappeared.
Partial response: Tumors shrink by at least 50% but some cancer cells remain.
Disease-free survival: Success is tracked by the duration a patient remains without relapse.
Minimal residual disease: Sensitive blood tests detect tiny traces of cancer standard scans miss.

Bookimed Expert Insight: Thailand’s leading facilities like Bumrungrad International Hospital serve over 1 million patients annually. Their high volume allows for specialized sub-units. We see success measured not just by remission, but by the precision of follow-up. Centers using JCI-accredited protocols integrate PET/CT and bone marrow biopsies into strict surveillance timelines. This rigorous monitoring often catches early changes before symptoms reappear, significantly improving long-term survival outcomes.

Patient Consensus: Patients often focus on reaching a No Evidence of Disease (NED) status. They emphasize that real success includes managing treatment toxicity to avoid lasting physical damage.

How soon can newly arrived international patients begin lymphoma treatment?

International patients typically begin lymphoma treatment in Thailand within 7 to 14 days after arrival. Major centers like Bumrungrad International Hospital require 3 to 5 business days for initial evaluations. Timelines depend heavily on the lymphoma subtype and pre-arrival preparation of medical records.

Initial evaluation: Comprehensive diagnostic reviews usually conclude within 3 to 5 business days.
Aggressive subtypes: Systemic therapy for aggressive cases often starts within 1 week of arrival.
Diagnostic methods: Clinics utilize PET/CT, bone marrow biopsy, and cytogenetic analysis for staging.
Pre-arrival prep: Submitting pathology slides 4 to 6 weeks early can shorten the timeline.

Bookimed Expert Insight: Thai facilities manage high volumes, with Bumrungrad International Hospital treating 1,000,000 patients annually. Our data shows that while clinical staging is fast, logistics like insurance verification and hospital registration often take 5 to 10 days. Patients should coordinate these administrative steps before flying to ensure treatment starts immediately after the 3-day diagnostic window.

Patient Consensus: Patients emphasize that having imaging and pathology reports ready before arrival can reduce the assessment period to less than a week. Many note that the multidisciplinary board review takes more time than the actual scheduling of the first chemotherapy session.

Where are the main centers offering high-complexity lymphoma therapy?

Main centers for high-complexity lymphoma therapy include JCI-accredited institutions like Bumrungrad International Hospital and major university hospitals. These facilities offer advanced protocols. These include allogeneic bone marrow transplantation and CAR T-cell therapy. Leading hematologists specialize in managing complex hematologic malignancies within multidisciplinary oncology departments.

Available therapies: Centers provide both autologous and allogeneic bone marrow transplantation options.
Diagnostic precision: Advanced diagnostics include PET-CT imaging and bone marrow punctures with cytogenetic analysis.
Clinical expertise: Specialists like Dr. Kodchanut Litleaungdej hold Thai Board of Hematology certifications.
Facility standards: Top hospitals maintain Joint Commission International (JCI) and Global Healthcare Accreditation.

Bookimed Expert Insight: While Bangkok remains the primary hub, the density of experts is significant. Bumrungrad International Hospital alone hosts 1,300 doctors and serves 1,000,000 patients annually. Our data shows that for complex blood cancers, choosing a center with academic ties is vital. Intrarat Hospital or university institutes often offer specialized hematology-oncology fellowships. This ensures access to the latest physician-led research protocols.

Patient Consensus: Patients note that Bangkok hospitals manage complicated oncology cases through multidisciplinary teams. Some advise checking for international lymphoma network participation when treating rare or treatment-resistant subtypes.

Will language be a barrier during consultations and inpatient care?

Language is not a barrier for lymphoma treatment in Thai international hospitals. Leading facilities provide certified medical interpreters for over 20 languages. Doctors often hold board certifications from the United States or United Kingdom. They communicate fluently in English during consultations and inpatient rounds.

Specialist fluency: Many hematology oncologists hold international board certifications and degrees.
Interpreter services: Staff provide real-time translation for complex medical discussions and consent.
International departments: Dedicated teams manage logistics and communication for thousands of global patients.
Translated documentation: Discharge instructions and chemotherapy protocols are provided in clear English.

Bookimed Expert Insight: Language proficiency is deeply linked to a clinic's international patient volume. Bumrungrad International Hospital treats over 500,000 foreign patients annually from 190 countries. In facilities with such high global traffic, English is the primary operational language. This ensures nurses and administrative staff can assist you without translation delays.

Which lymphoma subtype is most commonly treated in Thai centers?

Diffuse large B-cell lymphoma (DLBCL) is the most frequently treated subtype in Thailand. It accounts for up to 67% of non-Hodgkin lymphoma cases locally. Thai centers also manage significant volumes of marginal zone lymphoma. Many specialized facilities hold Joint Commission International (JCI) accreditation for oncology safety.

Dominant subtype: DLBCL represents 58% to 67% of non-Hodgkin cases in national registries.
Secondary subtypes: Marginal zone lymphoma is the second most common condition treated locally.
Rare subtypes: Follicular lymphoma incidence is lower than Western averages, at around 6% total.
Hospital capacity: Bumrungrad International Hospital serves over 1,000,000 patients annually with advanced oncology.
Specialized experts: Dr. Kodchanut Litleaungdej is a Thai Board of Hematology certified specialist.

Bookimed Expert Insight: While many patients focus solely on major cancer centers, Thai hematology expertise is deep. Leading specialists like Dr. Kodchanut Litleaungdej hold specific Thai Board of Hematology certifications. This ensures that even high-volume centers maintain personalized diagnostic standards for complex blood disorders.

Patient Consensus: Patients emphasize the importance of bringing original pathology slides to Bangkok. This helps avoid diagnostic delays. Many travelers also suggest verifying the hospital's specific experience with DLBCL caseloads during initial inquiries.

Los mejores médicos del tratamiento de Linfoma en Bangkok - TOP-1 médicos

Recibe cotizaciones de 3 de los mejores especialistas en en Tailandia